Ret-proto-oncogene analysis in medullary thyroid carcinoma (Q38469941)

3 September 2017

Ret-proto-oncogene analysis in medullary thyroid carcinoma (English)

1 reference

3 September 2017

O'Keeffe DA

1

1 reference

3 September 2017

Hill AD

2

1 reference

3 September 2017

Sheahan K

3

1 reference

3 September 2017

Ryan F

4

1 reference

3 September 2017

Barton D

5

1 reference

3 September 2017

Fitzgerald RJ

6

1 reference

3 September 2017

McDermott EW

7

1 reference

3 September 2017

O'Higgins NJ

8

1 reference

3 September 2017

1 October 1998

1 reference

Irish Journal of Medical Science

3 September 2017

1 reference

3 September 2017

167

1 reference

3 September 2017

4

1 reference

3 September 2017

226-230

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02937418

3 September 2017

0 references

cites work

Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02937418

Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A

21 January 2018

1 reference

12 December 2020

Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1 reference

12 December 2020

Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2

1 reference

12 December 2020

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

12 December 2020

Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients

1 reference

12 December 2020

Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976)

1 reference

12 December 2020

Family screening in medullary thyroid carcinoma presenting without a family history

1 reference

12 December 2020

Multiple endocrine neoplasia. Type IIa.

1 reference

12 December 2020

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

1 reference

12 December 2020

The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families

1 reference

12 December 2020

Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.

1 reference

12 December 2020

RET proto-oncogene mutations in French MEN 2A and FMTC families

1 reference

12 December 2020

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.

1 reference

12 December 2020

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC: s

1 reference

12 December 2020

Genetic aspects of multiple endocrine neoplasia

1 reference

12 December 2020

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

1 reference

12 December 2020

Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis

1 reference

12 December 2020

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience

1 reference

12 December 2020

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

12 December 2020

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

12 December 2020

Medullary carcinoma of the thyroid: current diagnosis and management

1 reference

12 December 2020

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1 reference

12 December 2020

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

12 December 2020

A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC

1 reference

12 December 2020

The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02937418

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference